Valuation: iSpecimen Inc.

Market Cap 3.7M 3.21M 3.02M 2.74M 5.15M 354M 5.19M 36.09M 13.9M 180M 13.9M 13.6M 571M P/E 2024
-0.15x
P/E 2025 -0.11x
Enterprise Value -2.91M -2.52M -2.38M -2.16M -4.04M -278M -4.08M -28.36M -10.92M -141M -10.93M -10.69M -449M EV / Sales 2024
0.11x
EV / Sales 2025 -2.11x
Free-Float
99.96%
Yield 2024 *
-
Yield 2025 -
1 week-4.55%
Current month-4.55%
1 month-36.09%
3 months-46.55%
6 months-87.08%
Current year-85.87%
1 week 1.38
Extreme 1.38
1.94
1 month 1.38
Extreme 1.38
2.59
Current year 1.38
Extreme 1.38
18
1 year 1.38
Extreme 1.38
86.4
3 years 1.38
Extreme 1.38
632
5 years 1.38
Extreme 1.38
23,183.92
10 years 1.38
Extreme 1.38
23,183.92
Manager TitleAgeSince
Chief Executive Officer 39 26/08/2026
Chief Executive Officer 32 07/11/2025
Director of Finance/CFO 36 13/12/2024
Director TitleAgeSince
Director/Board Member 31 25/09/2024
Director/Board Member 41 20/06/2025
Director/Board Member 35 07/11/2025
Date Insider Type Main position Quantity % Market Cap. Importance
25/9/24 Free

Chief Executive Officer

168 0.0013%
25/9/24 Free

Chairman

168 0.0013%
25/9/24 Free

Director

168 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.55%-98.12%-99.72% 3.7M
+1.97%+1.14%-0.88%+50.39% 3,680B
+3.64%-0.59%+1.10%+1,010.96% 402B
-3.56%-4.66%-18.76%+15.73% 79.69B
+4.00%+8.04%+68.53%+136.00% 79.43B
-4.01%-3.15%-10.35%-18.30% 76.15B
+2.30%-3.04%-44.57%+178.45% 65.07B
+7.27%+1.68%+10.24%-7.72% 45.49B
+3.45%+3.83%-9.48%+54.41% 40.29B
+1.99%-0.47%+126.60%+259.06% 34.92B
Average +0.98%-1.83%+2.43%+157.93% 450.32B
Weighted average by Cap. -0.12%-1.11%+0.44%+138.77%

Financials

2024 2025
Net sales 9.29M 8.04M 7.59M 6.88M 12.91M 888M 13.01M 90.56M 34.87M 452M 34.89M 34.12M 1.43B 1.93M 1.67M 1.58M 1.43M 2.68M 184M 2.7M 18.8M 7.24M 93.79M 7.24M 7.08M 298M
Net income -12.5M -10.82M -10.21M -9.26M -17.37M -1.19B -17.5M -122M -46.91M -608M -46.94M -45.9M -1.93B -10.49M -9.08M -8.57M -7.77M -14.58M -1B -14.69M -102M -39.36M -510M -39.39M -38.52M -1.62B
Net Debt -1.57M -1.36M -1.28M -1.16M -2.18M -150M -2.19M -15.27M -5.88M -76.15M -5.88M -5.75M -242M -6.61M -5.72M -5.4M -4.9M -9.19M -632M -9.26M -64.45M -24.82M -321M -24.83M -24.28M -1.02B
Logo iSpecimen Inc.
iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
Employees
7
Date Price Change Volume
14/09/26 USD 1.470 0.00% 159,987
11/09/26 USD 1.470 -2.00% 182,073
10/09/26 USD 1.500 -3.23% 532,970
09/09/26 USD 1.550 -2.52% 920,864

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ISPC Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!